The main purpose of this study is the comparison of frequency of vomiting episodes (number of episodes per year) observed during the year after the begin of Q10 coenzyme treatment to frequency observed during the year before the begin of this treatment in children with cyclic vomiting syndrome. Secondary purposes are the evaluation of life quality of parents and children, of treatment safety and its economic cost compared to other recommended treatments.
Study Type
OBSERVATIONAL
Enrollment
15
Children's Hospital - CHRU de Nancy
Vandœuvre-lès-Nancy, France
Frequency of vomiting episodes
measured by number of episodes per year
Time frame: from date of inclusion (start of Q10 coenzyme treatment) up to 1 year
Frequency of vomiting episodes
measured by number of episodes per year
Time frame: from 1 year before date of inclusion until date of inclusion (start of Q10 coenzyme treatment)
Intensity of vomiting episodes
reported by the child and/or parents
Time frame: from 1 year before date of inclusion until date of inclusion (start of Q10 coenzyme treatment)
Intensity of vomiting episodes
reported by the child and/or parents
Time frame: from date of inclusion (start of Q10 coenzyme treatment) up to 1 year
Number of child hospitalizations
Time frame: from 1 year before date of inclusion until date of inclusion (start of Q10 coenzyme treatment)
Number of child hospitalizations
Time frame: from date of inclusion (start of Q10 coenzyme treatment) up to 1 year
Cost of Q10 coenzyme treatment and other recommended treatments for cyclic vomiting syndrome
Time frame: baseline
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.